CommercialCoverageMedium impact
Genetic Testing for Mitochondrial Disorders
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Pediatrics, Endocrinology +4 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has published a comprehensive medical policy (A.2.04.117) defining coverage criteria for genetic testing for mitochondrial disorders. This policy establishes when genetic testing for conditions like MELAS, MERFF, and Leigh syndrome will be considered medically necessary, affecting billing for genetic testing services.
Action Required
Immediately: Review policy A.2.04.117 to understand coverage criteria for mitochondrial genetic testing. Billing team should verify patient symptoms match covered mitochondrial disorders (MELAS, MERFF, Kearns-Sayre, Leigh syndrome, etc.) before submitting genetic testing claims. Providers must document clinical manifestations consistent with mitochondrial diseases in medical records to support medical necessity.